Tender Notice for Piroxicam 40 mg, 2 ml Inj,Morphine 15 mg, 1 ml Inj,Pethedine 50 mg, 1 ml Inj,Methylprednisolone 16 in UTTARA KANNADA, KARNATAKA
Bid Publish Date
25-Feb-2025, 10:33 am
Bid End Date
18-Mar-2025, 11:00 am
Location
Progress
Quantity
27497
Categories
5
A tender has been published for Indian Navy Piroxicam 40 mg, 2 ml Inj, Morphine 15 mg, 1 ml Inj, Pethedine 50 mg, 1 ml Inj, Methylprednisolone 16 mg Tab, Promethazine HCl 2. 5 percentage, 25 mg per ml, 2 ml Inj, Leucoverin 15 mg Tab, Pralidoxime 500 mg per 20 ml Inj, Penicillamine 250 mg Tab, Tab Pramipexole 0. 25 mg, Methylphenidate 10 mg Tab, Glipizide 5mg Tab, Glibenclamide 5mg Tab, Insulin Highly Purified human neutral 40 IU per ml, 10 ml Inj, Linagliptin 2. 5 mg, Metformin 500 mg, Linagliptin 2. 5mg, Metformin 1000 mg, Insulin highly purified Isophane, Human NPH, 40 IU per ml, 10 ml Inj, Thyroxine Sodium 0. 025 mg Tab, Tab Metformin 500 mg, Tab Vildagliptin 50 mg in UTTARA KANNADA, KARNATAKA. Quantity: 27497 by. Submission Deadline: 18-03-2025 11: 00: 00. Check eligibility and apply.
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Item Category
Piroxicam 40 mg, 2 ml Inj , Morphine 15 mg, 1 ml Inj , Pethedine 50 mg, 1 ml Inj , Methylprednisolone 16 mg Tab , Promethazine HCl 2.5 percentage, 25 mg per ml, 2 ml Inj , Leucoverin 15 mg Tab , Pralidoxime 500 mg per 20 ml Inj , Penicillamine 250 mg Tab , Tab Pramipexole 0.25 mg , Methylphenidate 10 mg Tab , Glipizide 5mg Tab , Glibenclamide 5mg Tab , Insulin Highly Purified human neutral 40 IU per ml, 10 ml Inj , Linagliptin 2.5 mg, Metformin 500 mg , Linagliptin 2.5mg, Metformin 1000 mg , Insulin highly purified Isophane, Human NPH, 40 IU per ml, 10 ml Inj , Thyroxine Sodium 0.025 mg Tab , Tab Metformin 500 mg, Tab Vildagliptin 50 mg
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-7566739.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
18 Items Sign in to view GEM price trends Sign in for GEM prices
Piroxicam 40 mg, 2 ml Inj
Piroxicam 40 mg, 2 ml Inj
Morphine 15 mg, 1 ml Inj
Morphine 15 mg, 1 ml Inj
Pethedine 50 mg, 1 ml Inj
Pethedine 50 mg, 1 ml Inj
Methylprednisolone 16 mg Tab
Methylprednisolone 16 mg Tab
Promethazine HCl 2.5 percentage, 25 mg per ml, 2 ml Inj
Promethazine HCl 2.5 percentage, 25 mg per ml, 2 ml Inj
Leucoverin 15 mg Tab
Leucoverin 15 mg Tab
Pralidoxime 500 mg per 20 ml Inj
Pralidoxime 500 mg per 20 ml Inj
Penicillamine 250 mg Tab
Penicillamine 250 mg Tab
Tab Pramipexole 0.25 mg
Tab Pramipexole 0.25 mg
Methylphenidate 10 mg Tab
Methylphenidate 10 mg Tab
Glipizide 5mg Tab
Glipizide 5mg Tab
Glibenclamide 5mg Tab
Glibenclamide 5mg Tab
Insulin Highly Purified human neutral 40 IU per ml, 10 ml Inj
Insulin Highly Purified human neutral 40 IU per ml, 10 ml Inj
Linagliptin 2.5 mg, Metformin 500 mg
Linagliptin 2.5 mg, Metformin 500 mg
Linagliptin 2.5mg, Metformin 1000 mg
Linagliptin 2.5mg, Metformin 1000 mg
Insulin highly purified Isophane, Human NPH, 40 IU per ml, 10 ml Inj
Insulin highly purified Isophane, Human NPH, 40 IU per ml, 10 ml Inj
Thyroxine Sodium 0.025 mg Tab
Thyroxine Sodium 0.025 mg Tab
Tab Metformin 500 mg, Tab Vildagliptin 50 mg
Tab Metformin 500 mg, Tab Vildagliptin 50 mg
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Piroxicam 40 mg, 2 ml Inj | Piroxicam 40 mg, 2 ml Inj | 50 | nos | oicmsptj2 | 30 | |
| 2 | Morphine 15 mg, 1 ml Inj | Morphine 15 mg, 1 ml Inj | 90 | nos | oicmsptj2 | 30 | |
| 3 | Pethedine 50 mg, 1 ml Inj | Pethedine 50 mg, 1 ml Inj | 90 | nos | oicmsptj2 | 30 | |
| 4 | Methylprednisolone 16 mg Tab | Methylprednisolone 16 mg Tab | 60 | nos | oicmsptj2 | 30 | |
| 5 | Promethazine HCl 2.5 percentage, 25 mg per ml, 2 ml Inj | Promethazine HCl 2.5 percentage, 25 mg per ml, 2 ml Inj | 480 | nos | oicmsptj2 | 30 | |
| 6 | Leucoverin 15 mg Tab | Leucoverin 15 mg Tab | 60 | nos | oicmsptj2 | 30 | |
| 7 | Pralidoxime 500 mg per 20 ml Inj | Pralidoxime 500 mg per 20 ml Inj | 30 | nos | oicmsptj2 | 30 | |
| 8 | Penicillamine 250 mg Tab | Penicillamine 250 mg Tab | 3 | nos | oicmsptj2 | 30 | |
| 9 | Tab Pramipexole 0.25 mg | Tab Pramipexole 0.25 mg | 720 | nos | oicmsptj2 | 30 | |
| 10 | Methylphenidate 10 mg Tab | Methylphenidate 10 mg Tab | 360 | nos | oicmsptj2 | 30 | |
| 11 | Glipizide 5mg Tab | Glipizide 5mg Tab | 780 | nos | oicmsptj2 | 30 | |
| 12 | Glibenclamide 5mg Tab | Glibenclamide 5mg Tab | 720 | nos | oicmsptj2 | 30 | |
| 13 | Insulin Highly Purified human neutral 40 IU per ml, 10 ml Inj | Insulin Highly Purified human neutral 40 IU per ml, 10 ml Inj | 130 | nos | oicmsptj2 | 30 | |
| 14 | Linagliptin 2.5 mg, Metformin 500 mg | Linagliptin 2.5 mg, Metformin 500 mg | 1,800 | nos | oicmsptj2 | 30 | |
| 15 | Linagliptin 2.5mg, Metformin 1000 mg | Linagliptin 2.5mg, Metformin 1000 mg | 1,800 | nos | oicmsptj2 | 30 | |
| 16 | Insulin highly purified Isophane, Human NPH, 40 IU per ml, 10 ml Inj | Insulin highly purified Isophane, Human NPH, 40 IU per ml, 10 ml Inj | 24 | nos | oicmsptj2 | 30 | |
| 17 | Thyroxine Sodium 0.025 mg Tab | Thyroxine Sodium 0.025 mg Tab | 18,500 | nos | oicmsptj2 | 30 | |
| 18 | Tab Metformin 500 mg, Tab Vildagliptin 50 mg | Tab Metformin 500 mg, Tab Vildagliptin 50 mg | 1,800 | nos | oicmsptj2 | 30 |
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | AAP PHARMA Under PMA | - | 13-03-2025 15:40:01 | |
| 2 | PARESH PHARMACEUTICAL DISTRIBUTORS Under PMA | - | 17-03-2025 18:46:15 | |
| 3 | RS PHARMA Under PMA | - | 16-03-2025 17:56:54 | |
| 4 | SHIVMEDH PHARMA Under PMA | - | 16-03-2025 15:32:17 | |
| 5 | SUNIL PHARMACY Under PMA | - | 17-03-2025 20:19:48 |
Frequently Asked Questions
Key insights about KARNATAKA tender market
What are the eligibility requirements for participating in this tender?
The eligibility requirements include being a registered entity with the necessary licenses to operate in the pharmaceutical sector. Bidders must have a proven track record of experience in supplying pharmaceutical products to either government or private sector clients. Moreover, all required certifications pertinent to pharmaceutical trading must be obtained prior to submission.
What technical specifications must products meet?
All products supplied must meet the established technical specifications and adhere to the health and safety regulations specified by the Ministry of Defence. Additionally, they must be compliant with applicable quality standards and undergo necessary testing as stipulated in the tender documentation.
What is required regarding the Earnest Money Deposit (EMD)?
An Earnest Money Deposit (EMD) is mandatory for all bidders participating in this tender. The specific amount and submission guidelines for the EMD are detailed within the tender documents. This deposit serves to ensure bidder commitment and compliance throughout the tender process.
How must submissions be made for this tender?
Submissions must be made electronically through the designated platform as outlined in the tender details. All required documents need to be submitted before the deadline specified in the tender notification, and adherence to the proper format is essential for ensuring acceptance.
What benefits do Micro, Small, and Medium Enterprises (MSEs) have under this tender?
MSEs may benefit from special provisions designed to support their participation in government contracts. This could include concessions in deposit requirements, tailored support throughout the registration process, and a more accessible evaluation framework to promote inclusivity in the bidding process.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 4
GeM-Bidding-7566739.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS